Clinical trial
Copaxone in Age Related Macular Degeneration
NCT00466076 · Kaplan Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00466076 |
|---|---|
| Title | Copaxone in Age Related Macular Degeneration |
| Official title | Subcutaneous Copaxone as Treatment for Dry Age Related Macular Degeneration |
| Lead sponsor | Kaplan Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Macular Degeneration |
| Intervention type | Drug |
| Interventions | Copaxone (Glatiramer acetate) |
| Enrollment | 30 |
| Start date | Aug 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Apr 27, 2007 |
| Last update posted | Apr 27, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: